Now showing items 1-2 of 2
Effects of continuous subcutaneous insulin infusion (CSII) therapy on quality of life and patients' self-management: Clinical survey of routine clinical practice at Derby Teaching Hospital, UK
Continuous subcutaneous insulin infusion (CSII) therapy for Type 1 diabetes can provide long-term, sustained improvements in glycaemic control and a reduction in hypoglycaemia. We aimed to assess the impact of CSII on ...
Mid-Term Remission of Type 2 Diabetes Mellitus After Laparoscopic Roux En-Y Gastric Bypass
BACKGROUND: Laparoscopic Roux en-Y gastric bypass (LRYGB) is an established therapeutic modality for type 2 diabetes mellitus (T2DM). However, there is paucity of data on the outcomes of LRYGB on T2DM beyond 2 years. This ...